Researchers in the US report a potentially new therapeutic strategy for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Using...
A new CRISPR-dCas13 tool developed by French researchers modulates alternative splicing without altering gene expression. The RNA-editing system,...
In an article just published in Science, researchers at University of California Berkeley, Gladstone Institutes (San Francisco) and Lawrence Berkeley...
Based on an evolved bacterial adenosine deaminase, DECOR represents a significant advancement in RNA editing technology by providing a more precise,...
Huntington’s disease is a fatal condition, and despite decades of research, there is no known cure. The patient community may now have new hope in the...
The state of play in the field of CRISPR diagnostics has been changing rapidly. Here, Bryan DeChairo, CEO of Sherlock Biosciences, discusses the...
Researchers at Texas Biomedical Research Institute in San Antonio, Texas have developed a novel strategy to inhibit human immunodeficiency virus (HIV)...
As the COVID-19 pandemic continues to evolve with fluctuating restrictions worldwide, mass vaccine rollouts and the emergence of new variants, it's...